Journal Report

LEUKEMIA RESEARCH

Download PDF
Journal Information
Journal Title
LEUKEMIA RESEARCH
Publisher
PERGAMON-ELSEVIER SCIENCE LTD
ISSN
0145-2126
E-ISSN
1873-5835
Database
Clarivate
Domain
Health Sciences, Life Sciences, Physical Sciences, Social Sciences
Classification History
Year A+ A B C
2026 ✓ ✓
2025 ✓ ✓
2024 ✓ ✓
2023 ✓ ✓
2021/2022 ✓ ✓
2020 ✓ ✓
2019 ✓ ✓
2018 ✓
A journal may have more than one classification in the same year. All recorded classifications are displayed.
Recent Articles
Outpatient step-up dosing of teclistamab and talquetamab in relapsed or refractory
Kunal Shah, Paul Forrest, Ananya Garg et al.
2026-12 Vol. 171 Pages 108318
DOI: 10.1016/j.leukres.2026.108318
SRSF2-mutated acute myeloid leukemia: Mechanisms, clonal evolution, prognostic reappraisal, and emerging precision therapeutics
Ruirui Hu, Liwen Gao, Fei Hong et al.
2026-12 Vol. 171 Pages 108360
DOI: 10.1016/j.leukres.2026.108360
Advances in diagnosis and treatment of angioimmunoblastic T-cell lymphoma
Qiuyan Lin, Lei Fan, Haorui Shen
2026-12 Vol. 171 Pages 108334
DOI: 10.1016/j.leukres.2026.108334
Bone marrow gene methylation detection for prognostic evaluation in diffuse large B-cell lymphoma
Tianhua Zhao, Jingjing Liu, Liping Geng et al.
2026-12 Vol. 171 Pages 108355
DOI: 10.1016/j.leukres.2026.108355
Immune-mediated thrombosis in myeloproliferative neoplasms: Pathogenic pathways and clinical relevance
Hanlu Zhang, Hao Xiong, Xuege Guo et al.
2026-12 Vol. 171 Pages 108323
DOI: 10.1016/j.leukres.2026.108323
Financial burden to patients and informal carers of myelodysplastic syndromes in England: a modelled analysis stratified by transfusion dependence
Joab Williamson, Emma Searle, Austin Kulasekararaj
2026-12 Vol. 171 Pages 108346
DOI: 10.1016/j.leukres.2026.108346
Integrating a clinical database and institutional biobank to map the epidemiological landscape and survival outcomes of lymphoma in Saudi Arabia
Musa Fares Alzahrani, Ghazi Alotaibi, Sarah Sewaralthahab et al.
2026-12 Vol. 171 Pages 108357
DOI: 10.1016/j.leukres.2026.108357
Mini-hyper-CVD with low-dose inotuzumab ozogamicin is an effective induction strategy for adults with immunomodulatory drug-associated B-cell acute lymphoblastic leukemia
Leora Boussi, Ettaib El Marabti, Brian Shaffer et al.
2026-12 Vol. 171 Pages 108331
DOI: 10.1016/j.leukres.2026.108331
Comparison allogeneic hematopoietic stem cell transplantation and chemotherapy for consolidation in acute lymphoblastic leukemia in a Colombian Cohort. A propensity score matching analysis
Juan F. Combariza-Vallejo, Laura María Díaz-Correa
2026-12 Vol. 171 Pages 108330
DOI: 10.1016/j.leukres.2026.108330
Age over sibling: Younger unrelated donors provide superior outcomes compared to sibling donors in fully matched HCT in older AML/MDS patients
Witold Prejzner, Alicja Sadowska-Klasa, Johannes Lakner et al.
2026-12 Vol. 171 Pages 108328
DOI: 10.1016/j.leukres.2026.108328
Articles retrieved from Crossref.
Green Journals | https://www.green-journals.com | info@green-journals.com
Printed: November 9, 2026 02:11